Consequences of chondrocyte hypertrophy on osteoarthritic cartilage: Potential effect on angiogenesis

Osteoarthritis and Cartilage

Volumn 21, Issue 12, 2013, Pages 1913-1923

  Pesesse, L ^a   Sanchez, C ^a   Delcour, J P ^b   Bellahcene A ^c   Baudouin, C ^d   Msika, P ^d   Henrotin, Y ^a,e  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b Bois de l'Abbaye Hospital   (Belgium)

^c UNIVERSITY OF LIÈGE   (Belgium)

^d Expanscience Laboratories   (France)

^e Princess Paola Hospital   (Belgium)

Author keywords

Angiogenesis; Bone sialoprotein; Chondrocyte hypertrophy; Osteoarthritis

Indexed keywords

ALGINIC ACID; ANGIOGENIC FACTOR; ANGIOPOIETIN 1; BONE SIALOPROTEIN; CHONDROMODULIN 1; COLLAGEN TYPE 10; COLLAGENASE 3; FIBROBLAST GROWTH FACTOR 2; GELATINASE A; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; NERVE GROWTH FACTOR; OSTEOPONTIN; PROTEIN; THROMBOSPONDIN 1; THROMBOSPONDIN 2; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG; VASCULOTROPIN;

ARTICLE; CARTILAGE; CARTILAGE CELL; CELL ADHESION; CELL DIFFERENTIATION; CELL INVASION; CELL MIGRATION; CELL STRUCTURE; CHONDROCYTE HYPERTROPHY; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HYPERTROPHY; MINERALIZATION; NEOVASCULARIZATION (PATHOLOGY); OSTEOARTHRITIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION; RNA ISOLATION; TOTAL KNEE REPLACEMENT; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION; WESTERN BLOTTING; WOUND HEALING;

ANGIOGENESIS; BONE SIALOPROTEIN; CHONDROCYTE HYPERTROPHY; OSTEOARTHRITIS;

ANGIOPOIETIN-1; CARTILAGE, ARTICULAR; CELL ADHESION; CELL MOVEMENT; CELLS, CULTURED; CHONDROCYTES; ENDOTHELIAL CELLS; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION REGULATION; HUMANS; HYPERTROPHY; INTEGRIN-BINDING SIALOPROTEIN; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MATRIX METALLOPROTEINASE 2; MEMBRANE PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; NERVE GROWTH FACTOR; OSTEOARTHRITIS; OSTEOPONTIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THROMBOSPONDIN 1; THROMBOSPONDINS; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84888873366     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2013.08.018     Document Type: Article

References (48)

1. Wang M., Shen J., Jin H., Im H.J., Sandy J., Chen D. Recent progress in understanding molecular mechanisms of cartilage degeneration during osteoarthritis. Ann N Y Acad Sci 2011, 1240:61-69.
2. Troeberg L., Nagase H. Proteases involved in cartilage matrix degradation in osteoarthritis. Biochim Biophys Acta 1824, 2012:133-145.
3. Mueller M.B., Tuan R.S. Anabolic/catabolic balance in pathogenesis of osteoarthritis: identifying molecular targets. PM R 2011, 3:S3-S11.
4. von der Mark K., Kirsch T., Nerlich A., Kuss A., Weseloh G., Gluckert K., et al. Type X collagen synthesis in human osteoarthritic cartilage. Indication of chondrocyte hypertrophy. Arthritis Rheum 1992, 35:806-811.
5. Solomon L.A., Berube N.G., Beier F. Transcriptional regulators of chondrocyte hypertrophy. Birth Defects Res C Embryo Today 2008, 84:123-130.
6. Nurminskaya M., Linsenmayer T.F. Identification and characterization of up-regulated genes during chondrocyte hypertrophy. Dev Dyn 1996, 206:260-271.
7. Fuerst M., Bertrand J., Lammers L., Dreier R., Echtermeyer F., Nitschke Y., et al. Calcification of articular cartilage in human osteoarthritis. Arthritis Rheum 2009, 60:2694-2703.
8. Suri S., Gill S.E., Massena de Camin S., Wilson D., McWilliams D.F., Walsh D.A. Neurovascular invasion at the osteochondral junction and in osteophytes in osteoarthritis. Ann Rheum Dis 2007, 66:1423-1428.
9. Sanchez C., Deberg M.A., Piccardi N., Msika P., Reginster J.Y., Henrotin Y.E. Osteoblasts from the sclerotic subchondral bone downregulate aggrecan but upregulate metalloproteinases expression by chondrocytes. This effect is mimicked by interleukin-6, -1beta and oncostatin M pre-treated non-sclerotic osteoblasts. Osteoarthritis Cartilage 2005, 13:979-987.
10. Collins D.H. Osteoarthritis. The Pathology of Articular and Spinal Diseases 1949, 74-115. London. E. Arnold (Ed.).
11. Petit B., Masuda K., D'Souza A.L., Otten L., Pietryla D., Hartmann D.J., et al. Characterization of crosslinked collagens synthesized by mature articular chondrocytes cultured in alginate beads: comparison of two distinct matrix compartments. Exp Cell Res 1996, 225:151-161.
12. Labarca C., Paigen K. Asimple, rapid, and sensitive DNA assay procedure. Anal Biochem 1980, 102:344-352.
13. Sanchez C., Pesesse L., Gabay O., Delcour J.P., Msika P., Baudouin C., et al. Regulation of subchondral bone osteoblast metabolism by cyclic compression. Arthritis Rheum 2012, 64:1193-1203.
14. Lamour V., Detry C., Sanchez C., Henrotin Y., Castronovo V., Bellahcene A. Runx2- and histone deacetylase 3-mediated repression is relieved in differentiating human osteoblast cells to allow high bone sialoprotein expression. JBiol Chem 2007, 282:36240-36249.
15. Jaffe E.A., Nachman R.L., Becker C.G., Minick C.R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. JClin Invest 1973, 52:2745-2756.
16. Fisher L.W., Whitson S.W., Avioli L.V., Termine J.D. Matrix sialoprotein of developing bone. JBiol Chem 1983, 258:12723-12727.
17. De Ceuninck F., Lesur C., Pastoureau P., Caliez A., Sabatini M. Culture of chondrocytes in alginate beads. Methods Mol Med 2004, 100:15-22.
18. Sanchez C., Deberg M.A., Msika P., Baudouin C., Henrotin Y.E. Study of the invitro conditions promoting hypertrophic differentiation of osteoarthritic articular chondrocytes. Ann Rheum Dis 2008, 67(Suppl II):462.
19. Dreier R. Hypertrophic differentiation of chondrocytes in osteoarthritis: the developmental aspect of degenerative joint disorders. Arthritis Res Ther 2010, 12:216.
20. van der Kraan P.M., van den Berg W.B. Chondrocyte hypertrophy and osteoarthritis: role in initiation and progression of cartilage degeneration?. Osteoarthritis Cartilage 2012, 20:223-232.
21. Wang X., Manner P.A., Horner A., Shum L., Tuan R.S., Nuckolls G.H. Regulation of MMP-13 expression by RUNX2 and FGF2 in osteoarthritic cartilage. Osteoarthritis Cartilage 2004, 12:963-973.
22. Song R.H., Tortorella M.D., Malfait A.M., Alston J.T., Yang Z., Arner E.C., et al. Aggrecan degradation in human articular cartilage explants is mediated by both ADAMTS-4 and ADAMTS-5. Arthritis Rheum 2007, 56:575-585.
23. James C.G., Appleton C.T., Ulici V., Underhill T.M., Beier F. Microarray analyses of gene expression during chondrocyte differentiation identifies novel regulators of hypertrophy. Mol Biol Cell 2005, 16:5316-5333.
24. Dong Y.F., Soung do Y., Schwarz E.M., O'Keefe R.J., Drissi H. Wnt induction of chondrocyte hypertrophy through the Runx2 transcription factor. JCell Physiol 2006, 208:77-86.
25. Kirsch T., Swoboda B., Nah H. Activation of annexin II and V expression, terminal differentiation, mineralization and apoptosis in human osteoarthritic cartilage. Osteoarthritis Cartilage 2000, 8:294-302.
26. Ea H.K. Avancées pathogéniques des mécanismes de calcification du cartilage. Revue du rhumatisme 2007, 74:168-172.
27. Wei P.L., Kuo L.J., Wang W., Lin F.Y., Liu H.H., How T., et al. Silencing of glucose-regulated protein 78 (GRP78) enhances cell migration through the upregulation of vimentin in hepatocellular carcinoma cells. Ann Surg Oncol 2011.
28. Rahim S., Uren A. Areal-time electrical impedance based technique to measure invasion of endothelial cell monolayer by cancer cells. JVis Exp 2011.
29. Pirotte S., Lamour V., Lambert V., Alvarez Gonzalez M.L., Ormenese S., Noel A., et al. Dentin matrix protein 1 induces membrane expression of VE-cadherin on endothelial cells and inhibits VEGF-induced angiogenesis by blocking VEGFR-2 phosphorylation. Blood 2011, 117:2515-2526.
30. Rodriguez L.G., Wu X., Guan J.L. Wound-healing assay. Methods Mol Biol 2005, 294:23-29.
31. Vailhe B., Vittet D., Feige J.J. Invitro models of vasculogenesis and angiogenesis. Lab Invest 2001, 81:439-452.
32. Maciag T., Kadish J., Wilkins L., Stemerman M.B., Weinstein R. Organizational behavior of human umbilical vein endothelial cells. JCell Biol 1982, 94:511-520.
33. Walsh D.A., Bonnet C.S., Turner E.L., Wilson D., Situ M., McWilliams D.F. Angiogenesis in the synovium and at the osteochondral junction in osteoarthritis. Osteoarthritis Cartilage 2007, 15:743-751.
34. Franses R.E., McWilliams D.F., Mapp P.I., Walsh D.A. Osteochondral angiogenesis and increased protease inhibitor expression in OA. Osteoarthritis Cartilage 2010, 18:563-571.
35. Bonnet C.S., Walsh D.A. Osteoarthritis, angiogenesis and inflammation. Rheumatology (Oxford) 2005, 44:7-16.
36. Ferrara N., Gerber H.P. The role of vascular endothelial growth factor in angiogenesis. Acta Haematol 2001, 106:148-156.
37. Przybylski M. Areview of the current research on the role ofbFGF and VEGF in angiogenesis. JWound Care 2009, 18:516-519.
38. Nico B., Mangieri D., Benagiano V., Crivellato E., Ribatti D. Nerve growth factor as an angiogenic factor. Microvasc Res 2008, 75:135-141.
39. Wang Y., Yan W., Lu X., Qian C., Zhang J., Li P., et al. Overexpression of osteopontin induces angiogenesis of endothelial progenitor cells via the avbeta3/PI3K/AKT/eNOS/NO signaling pathway in glioma cells. Eur J Cell Biol 2011, 90:642-648.
40. Bellahcene A., Bonjean K., Fohr B., Fedarko N.S., Robey F.A., Young M.F., et al. Bone sialoprotein mediates human endothelial cell attachment and migration and promotes angiogenesis. Circ Res 2000, 86:885-891.
41. Jackson C. Matrix metalloproteinases and angiogenesis. Curr Opin Nephrol Hypertens 2002, 11:295-299.
42. Armstrong L.C., Bornstein P. Thrombospondins 1 and 2 function as inhibitors of angiogenesis. Matrix Biol 2003, 22:63-71.
43. Shukunami C., Oshima Y., Hiraki Y. Chondromodulin-I and tenomodulin: a new class of tissue-specific angiogenesis inhibitors found in hypovascular connective tissues. Biochem Biophys Res Commun 2005, 333:299-307.
44. Thurston G., Rudge J.S., Ioffe E., Zhou H., Ross L., Croll S.D., et al. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med 2000, 6:460-463.
45. Fukuhara S., Sako K., Minami T., Noda K., Kim H.Z., Kodama T., et al. Differential function of Tie2 at cell-cell contacts and cell-substratum contacts regulated by angiopoietin-1. Nat Cell Biol 2008, 10:513-526.
46. De Spiegelaere W., Cornillie P., Van den Broeck W., Plendl J., Bahramsoltani M. Angiopoietins differentially influence invitro angiogenesis by endothelial cells of different origin. Clin Hemorheol Microcirc 2011, 48:15-27.
47. Ribatti D., Vacca A., Presta M. The discovery of angiogenic factors: a historical review. Gen Pharmacol 2001, 35:227-231.
48. Ribatti D., Nico B., Crivellato E., Roccaro A.M., Vacca A. The history of the angiogenic switch concept. Leukemia 2007, 21:44-52.